Midori Kjellin
Doktorand vid Institutionen för medicinska vetenskaper; Klinisk Mikrobiologi
- Telefon:
- 018-61 13 91
- Mobiltelefon:
- 070-512 19 34
- E-post:
- midori.kjellin@medsci.uu.se
- Besöksadress:
- Dag Hammarskjölds väg 38
- Postadress:
- Klinisk Mikrobiologi, Hub
Dag Hammarskjölds väg 38
751 85 Uppsala
Mer information visas för dig som medarbetare om du loggar in.
Publikationer
Senaste publikationer
- Detection and isolation of airborne SARS-CoV-2 in a hospital setting (2022)
- Characteristics of hepatitis C virus resistance in an international cohort after a decade of direct-acting antivirals (2022)
- Plaque-forming units from air samples (2022)
- Study of Resistance in Hepatitis C Virus Prior to Treatment with Direct Acting Antivirals (2020)
- Effect of the baseline Y93H resistance-associated substitution in HCV genotype 3 for direct-acting antiviral treatment (2019)
Alla publikationer
Artiklar
- Detection and isolation of airborne SARS-CoV-2 in a hospital setting (2022)
- Characteristics of hepatitis C virus resistance in an international cohort after a decade of direct-acting antivirals (2022)
- Plaque-forming units from air samples (2022)
- Effect of the baseline Y93H resistance-associated substitution in HCV genotype 3 for direct-acting antiviral treatment (2019)
- A Real World Resistance Profile of Virologic Failures Collected from an International Collaboration (SHARED) (2018)
- Personalized treatment of hepatitis C genotype 1a in Norway and Sweden 2014-2016 (2018)
- The effect of the first-generation HCV-protease inhibitors boceprevir and telaprevir and the relation to baseline NS3 resistance mutations in genotype 1 (2018)
- Prevalence of polymorphisms with significant resistance to NS5A inhibitors in treatment-naive patients with hepatitis C virus genotypes 1a and 3a in Sweden (2015)